Nature nominee quercetin's anti-influenza combat strategy-Demonstrations and remonstrations

Enkhtaivan Gansukh; Manikandan Muthu; Diby Paul; Gopal Ethiraj; Sechul Chun; Judy Gopal

doi:10.1002/rmv.1930

Nature nominee quercetin's anti-influenza combat strategy-Demonstrations and remonstrations

Rev Med Virol. 2017 May;27(3):e1930. doi: 10.1002/rmv.1930.

Authors

Enkhtaivan Gansukh¹, Manikandan Muthu¹, Diby Paul², Gopal Ethiraj¹, Sechul Chun¹, Judy Gopal¹

Affiliations

¹ Department of Bioresource and Food Science, Konkuk University, Seoul, South Korea.
² Environmental Microbiology, Department of Environmental Engineering, Konkuk University, Seoul, South Korea.

PMID: 31211498
DOI: 10.1002/rmv.1930

Abstract

Nature's providences are rather the choicest remedies for human health and welfare. One such is quercetin, which is nature's nominee for cancer cure and recently demonstrated against influenza attack. Quercetin is highly recognized for its anticancer applications. This review emphasizes on yet another gift that this compound has to offer for mankind, which is none other than combating the deadly evasive influenza virus. The chemistry of this natural bioflavonoid and its derivatives and its modus operandi against influenza virus is consolidated into this review. The advancements and achievements made in the anti-influenza clinical history are also documented. Further, the challenges facing the progress of this compound to emerge as a predominant anti-influenza drug are discussed, and the future perspective for breaking its limitations through integration with nanoplatforms is envisioned.

Keywords: bioflavonoid; challenges; influenza; natural product; quercetin; virus.

Publication types

Review